Find Trimagnesium Dicitrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

Canada

0

Australia

0

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

190RELATED EXCIPIENT COMPANIES

299EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Magnesium citrate dibasic, anhydrous, 144-23-0, 7779-25-1, Magnesiumcitrate(x:1), Magnesium citrate(x:1), Akos028109527
Molecular Formula
C6H6MgO7
Molecular Weight
214.41  g/mol
InChI Key
DIXGJWCZQHXZNR-UHFFFAOYSA-L

Trimagnesium Dicitrate
1 2D Structure

Trimagnesium Dicitrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
magnesium;2-(carboxymethyl)-2-hydroxybutanedioate
2.1.2 InChI
InChI=1S/C6H8O7.Mg/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+2/p-2
2.1.3 InChI Key
DIXGJWCZQHXZNR-UHFFFAOYSA-L
2.1.4 Canonical SMILES
C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.[Mg+2]
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Magnesium Citrate Dibasic, Anhydrous

2. 144-23-0

3. 7779-25-1

4. Magnesiumcitrate(x:1)

5. Magnesium Citrate(x:1)

6. Akos028109527

7. J-007935

2.3 Create Date
2012-08-08
3 Chemical and Physical Properties
Molecular Weight 214.41 g/mol
Molecular Formula C6H6MgO7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count3
Exact Mass213.9963942 g/mol
Monoisotopic Mass213.9963942 g/mol
Topological Polar Surface Area138 Ų
Heavy Atom Count14
Formal Charge0
Complexity234
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

API Stability Enhancers

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Empty Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Vegetarian Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 144-23-0 / Trimagnesium Dicitrate API manufacturers, exporters & distributors?

Trimagnesium Dicitrate manufacturers, exporters & distributors 1

87

PharmaCompass offers a list of Trimagnesium Dicitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Trimagnesium Dicitrate manufacturer or Trimagnesium Dicitrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trimagnesium Dicitrate manufacturer or Trimagnesium Dicitrate supplier.

API | Excipient name

Trimagnesium Dicitrate

Synonyms

Magnesium citrate dibasic, anhydrous, 144-23-0, 7779-25-1, Magnesiumcitrate(x:1), Magnesium citrate(x:1), Akos028109527

Cas Number

144-23-0

3344-18-1 Manufacturers

A 3344-18-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3344-18-1, including repackagers and relabelers. The FDA regulates 3344-18-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3344-18-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 3344-18-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

3344-18-1 Suppliers

A 3344-18-1 supplier is an individual or a company that provides 3344-18-1 active pharmaceutical ingredient (API) or 3344-18-1 finished formulations upon request. The 3344-18-1 suppliers may include 3344-18-1 API manufacturers, exporters, distributors and traders.

click here to find a list of 3344-18-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

3344-18-1 USDMF

A 3344-18-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of 3344-18-1 active pharmaceutical ingredient (API) in detail. Different forms of 3344-18-1 DMFs exist exist since differing nations have different regulations, such as 3344-18-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A 3344-18-1 DMF submitted to regulatory agencies in the US is known as a USDMF. 3344-18-1 USDMF includes data on 3344-18-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3344-18-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of 3344-18-1 suppliers with USDMF on PharmaCompass.

3344-18-1 CEP

A 3344-18-1 CEP of the European Pharmacopoeia monograph is often referred to as a 3344-18-1 Certificate of Suitability (COS). The purpose of a 3344-18-1 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 3344-18-1 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 3344-18-1 to their clients by showing that a 3344-18-1 CEP has been issued for it. The manufacturer submits a 3344-18-1 CEP (COS) as part of the market authorization procedure, and it takes on the role of a 3344-18-1 CEP holder for the record. Additionally, the data presented in the 3344-18-1 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 3344-18-1 DMF.

A 3344-18-1 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 3344-18-1 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of 3344-18-1 suppliers with CEP (COS) on PharmaCompass.

3344-18-1 WC

A 3344-18-1 written confirmation (3344-18-1 WC) is an official document issued by a regulatory agency to a 3344-18-1 manufacturer, verifying that the manufacturing facility of a 3344-18-1 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 3344-18-1 APIs or 3344-18-1 finished pharmaceutical products to another nation, regulatory agencies frequently require a 3344-18-1 WC (written confirmation) as part of the regulatory process.

click here to find a list of 3344-18-1 suppliers with Written Confirmation (WC) on PharmaCompass.

3344-18-1 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 3344-18-1 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for 3344-18-1 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture 3344-18-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain 3344-18-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 3344-18-1 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of 3344-18-1 suppliers with NDC on PharmaCompass.

3344-18-1 GMP

3344-18-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of 3344-18-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right 3344-18-1 GMP manufacturer or 3344-18-1 GMP API supplier for your needs.

3344-18-1 CoA

A 3344-18-1 CoA (Certificate of Analysis) is a formal document that attests to 3344-18-1's compliance with 3344-18-1 specifications and serves as a tool for batch-level quality control.

3344-18-1 CoA mostly includes findings from lab analyses of a specific batch. For each 3344-18-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

3344-18-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (3344-18-1 EP), 3344-18-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3344-18-1 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty